BBBuket Yilmaz Bulbul

Buket Yilmaz Bulbul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Buket Yilmaz Bulbul has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Relationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus

    by Yagmur Ucar Yagcı, Buket Yılmaz Bulbul, Necdet Sut, Eray Ozgun

    Objectives: We aimed to investigate the relationship between serum paraoxonase-1 (PON1) and paraoxonase-3 (PON3) levels and activities with hemoglobin A1c (HbA 1c ), serum fasting blood glucose, lipid profile, and oxidative stress in patients with type 2 diabetes mellitus (T2DM). Also, we aimed to examine PON1 and PON3 levels and activities in these patients according to the HbA 1c goal in diabetes treatment and PON1 192 phenotypes. Methods: One hundred forty-one volunteers diagnosed with T2DM participated in this study. Serum PON1 and PON3 levels and activities, total oxidant status (TOS), and total antioxidant status (TAS) were measured. PON1 192 phenotypes were determined by using PON1 activities. Also, HbA 1c , serum fasting blood glucose, and lipid profile results, which were measured for routine examination on the same day as sample collection, were used for this study. Results: There was a positive relationship between arylesterase and lactonase activities and high-density lipoprotein cholesterol (HDL-C), between lactonase activity and TAS, and a negative relationship between PON1 level and TAS in patients with T2DM. Our study also showed that PON3/HDL-C was higher in patients with HbA 1c levels ≥7 %. Lactonase activities were higher in patients with PON1 Q192Q and PON1 Q192R phenotypes than in patients with PON1 R192R phenotypes. Conclusions: PON1 and PON3 levels and activities alone could not be associated with immediate or long-term blood glucose levels in patients with T2DM. Higher PON3/HDL-C in patients with HbA 1c levels ≥7 % may show a protective role of PON3 in defense against higher glucose levels. Also, we found that the PON1 192 phenotype can affect serum lactonase activity.


  • Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up

    by Serpil Yanik Çolak, Eray Özgün, Burak Andaç, Mine Okur, Buket Yilmaz Bülbül, Mehmet Çeli̇k

  • Open Access

    25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control

    by Burak Andaç, Buket Yılmaz Bülbül, Mehmet Oğulcan Tezel, Mine Okur, Serpil Yanık Çolak, Buse Ekici, Mehmet Celik

    Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.

  • Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation

    by Mehmet Celik, Sibel Guldiken, Semra Ayturk, Buket Yilmaz Bulbul, Ahmet Kucukarda, Nuray Can, Ebru Tastekin, Atakan Sezer, Necdet Sut, Armagan Tugrul, et al.